These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2866312)

  • 1. Progenitor cells and classification of myelodysplastic and myeloproliferative disorders.
    Harris PF
    Lancet; 1985 Nov; 2(8466):1240. PubMed ID: 2866312
    [No Abstract]   [Full Text] [Related]  

  • 2. Progenitor cells and classification of myelodysplastic and myeloproliferative disorders.
    Brown G; Bunce CM; Rose PE; Howie AJ
    Lancet; 1985 Oct; 2(8460):885. PubMed ID: 2864593
    [No Abstract]   [Full Text] [Related]  

  • 3. Is chronic myelomonocytic leukemia more akin to myelodysplastic or myeloproliferative neoplasms and does it matter?
    Tefferi A
    Leuk Lymphoma; 2008 Jul; 49(7):1225-7. PubMed ID: 18604709
    [No Abstract]   [Full Text] [Related]  

  • 4. The myelodysplastic syndromes and myeloproliferative disorders.
    Williams JL
    Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    Cazzola M
    Haematologica; 2011 Mar; 96(3):349-52. PubMed ID: 21357714
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
    Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618
    [No Abstract]   [Full Text] [Related]  

  • 7. The monocytic component in myelodysplastic syndromes.
    Castoldi G; Rigolin GM
    Cancer Treat Res; 2001; 108():81-92. PubMed ID: 11702607
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes.
    Breccia M; Federico V; Loglisci G; Salaroli A; Serrao A; Alimena G
    Haematologica; 2011 Oct; 96(10):e41-2. PubMed ID: 21972212
    [No Abstract]   [Full Text] [Related]  

  • 9. The WHO classification of the myelodysplastic syndromes.
    Bain B
    Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.
    Vardiman JW
    Semin Diagn Pathol; 2003 Aug; 20(3):154-79. PubMed ID: 14552429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 16. [A revised 4 edition WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2017: myeloid neoplasms].
    Kovrigina AM
    Arkh Patol; 2018; 80(6):43-49. PubMed ID: 30585592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new WHO nomenclature: introduction and myeloid neoplasms.
    Rodak BF; Leclair SJ
    Clin Lab Sci; 2002; 15(1):44-54. PubMed ID: 12778956
    [No Abstract]   [Full Text] [Related]  

  • 19. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
    Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
    Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.